HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Present status of home therapy cancer patients using an infusor].

Abstract
We started a department of medical oncology and the risk management system of cancer chemotherapy since April in 2004. After that, chemotherapy administration increased steadily in numbers, especially on an outpatient basis. For reliable venous access, we made active use of a central venous Port (more than 60% of cases) as a rout of administration. Fifty five patients with advanced colorectal cancer were treated by FOLFIRI or FOLFOX regimen from April 2005 to June 2006. Two hundred sixty four cycles of FOLFIRI and 276 cycles of FOLFOX were administered. One hundred sixteen cycles (44%) and 117 cycles (42%) were performed through home therapy, respectively. Twenty five out of 55 patients could shift to home therapy using an infusor. Nine out of 30 patients wanted to continue on an inpatient basis, because their private insurance for medical care did not support the outpatient chemotherapy.
AuthorsYasushi Tsuji, Takahiro Tsushima, Shingo Tanaka, Takeshi Mizushima, Fumihito Tamura, Hiroki Chiba, Kana Honda, Kiyoko Makino, Kae Ohura, Tetsuya Sumiyoshi, Naohito Yoshizaki, Hitoshi Kondo
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 33 Suppl 2 Pg. 260-3 (Dec 2006) ISSN: 0385-0684 [Print] Japan
PMID17469354 (Publication Type: Journal Article)
Chemical References
  • Organoplatinum Compounds
  • Leucovorin
  • Fluorouracil
  • Camptothecin
Topics
  • Ambulatory Care
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage, therapeutic use)
  • Camptothecin (administration & dosage, analogs & derivatives)
  • Colorectal Neoplasms (drug therapy)
  • Drug Administration Schedule
  • Fluorouracil (administration & dosage)
  • Home Care Services
  • Humans
  • Infusion Pumps (statistics & numerical data)
  • Infusion Pumps, Implantable
  • Leucovorin (administration & dosage)
  • Organoplatinum Compounds (administration & dosage)
  • Risk Management

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: